{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T08:18:38Z","timestamp":1758442718426,"version":"3.44.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,19]]},"DOI":"10.7759\/cureus.92761","type":"journal-article","created":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T06:06:13Z","timestamp":1758348373000},"source":"Crossref","is-referenced-by-count":0,"title":["Topical Prednisolone Acetate Challenge as a Predictor of Intraocular Pressure Elevation Following Ozurdex\u00ae in Diabetic Macular Edema: A Retrospective Study"],"prefix":"10.7759","author":[{"given":"Ahmed B","family":"Alsatrawi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasan  B","family":"Alhaddar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali R","family":"Mubarak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1963.00960050484010","article-title":"Effect of corticosteroids on intraocular pressure and fluid dynamics: II. The effect of dexamethasone in the glaucomatous eye","volume":"70","author":"Armaly MF","year":"1963","unstructured":"Armaly MF. Effect of corticosteroids on intraocular pressure and fluid dynamics: II. The effect of dexamethasone in the glaucomatous eye. Arch Ophthalmol. 1963, 70:482-91. 10.1001\/archopht.1963.00960050484010","journal-title":"Arch Ophthalmol"},{"key":"ref2","article-title":"Intraocular pressure response to topical corticosteroids","volume":"4","author":"Becker B","year":"1965","unstructured":"Becker B. Intraocular pressure response to topical corticosteroids. Invest Ophthalmol. 1965, 4:198-205.","journal-title":"Invest Ophthalmol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6701895","article-title":"Corticosteroid-induced glaucoma: a review of the literature","volume":"20","author":"Kersey JP","year":"2006","unstructured":"Kersey JP, Broadway DC. Corticosteroid-induced glaucoma: a review of the literature. Eye (Lond). 2006, 20:407-16. 10.1038\/sj.eye.6701895","journal-title":"Eye (Lond)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/cells12202452","article-title":"Role of glucocorticoids and Glucocorticoid receptors in glaucoma pathogenesis","volume":"12","author":"Patel PD","year":"2023","unstructured":"Patel PD, Kodati B, Clark AF. Role of glucocorticoids and Glucocorticoid receptors in glaucoma pathogenesis. Cells. 2023, 12:2452. 10.3390\/cells12202452","journal-title":"Cells"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2011.05.014","article-title":"Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results","volume":"118","author":"Haller JA","year":"2011","unstructured":"Haller JA, Bandello F, Belfort R Jr, et al.. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. Ophthalmology. 2011, 118:2453-60. 10.1016\/j.ophtha.2011.05.014","journal-title":"Ophthalmology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000000839","article-title":"New insight into the macular deep vascular plexus imaged by optical coherence tomography angiography","volume":"35","author":"Bonnin S","year":"2015","unstructured":"Bonnin S, Man\u00e9 V, Couturier A, Julien M, Paques M, Tadayoni R, Gaudric A. New insight into the macular deep vascular plexus imaged by optical coherence tomography angiography. Retina. 2015, 35:2347-52. 10.1097\/IAE.0000000000000839","journal-title":"Retina"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0209997","article-title":"Long-term probability of intraocular pressure elevation with the intravitreal dexamethasone implant in the real-world","volume":"14","author":"Zarranz-Ventura J","year":"2019","unstructured":"Zarranz-Ventura J, Sala-Puigdollers A, Velazquez-Villoria D, et al.. Long-term probability of intraocular pressure elevation with the intravitreal dexamethasone implant in the real-world. PLoS One. 2019, 14:e0209997. 10.1371\/journal.pone.0209997","journal-title":"PLoS One"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/ojo.ojo_326_21","article-title":"Ocular hypertension and its predictor after a single Ozurdex implant: one-year follow-up in Asian Indian eyes","volume":"15","author":"Mansoori T","year":"2022","unstructured":"Mansoori T, Shiva S, Balakrishna N. Ocular hypertension and its predictor after a single Ozurdex implant: one-year follow-up in Asian Indian eyes. Oman J Ophthalmol. 2022, 15:299-303. 10.4103\/ojo.ojo_326_21","journal-title":"Oman J Ophthalmol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2004.06.067","article-title":"Intravitreal triamcinolone acetonide and intraocular pressure","volume":"138","author":"Smithen LM","year":"2004","unstructured":"Smithen LM, Ober MD, Maranan L, Spaide RF. Intravitreal triamcinolone acetonide and intraocular pressure. Am J Ophthalmol. 2004, 138:740-3. 10.1016\/j.ajo.2004.06.067","journal-title":"Am J Ophthalmol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000001369","article-title":"Safety of intravitreal dexamethasone implant (Ozurdex): the Safodex study. Incidence and risk factors of ocular hypertension","volume":"37","author":"Malcl\u00e8s A","year":"2017","unstructured":"Malcl\u00e8s A, Dot C, Voirin N, et al.. Safety of intravitreal dexamethasone implant (Ozurdex): the Safodex study. Incidence and risk factors of ocular hypertension. Retina. 2017, 37:1352-9. 10.1097\/IAE.0000000000001369","journal-title":"Retina"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1454591","article-title":"Long term efficacy and safety profile of dexamethasone intravitreal implant in retinal vein occlusions: a systematic review","volume":"11","author":"Carnevali A","year":"2024","unstructured":"Carnevali A, Bacherini D, Metrangolo C, et al.. Long term efficacy and safety profile of dexamethasone intravitreal implant in retinal vein occlusions: a systematic review. Front Med (Lausanne). 2024, 11:1454591. 10.3389\/fmed.2024.1454591","journal-title":"Front Med (Lausanne)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4103\/erj.erj_8_21","article-title":"Safety and long-term outcomes of repeated dexamethasone intravitreal implant (Ozurdex\u00ae) for the management of macular edema: real-life study","volume":"8","author":"Abdellaoui M","year":"2021","unstructured":"Abdellaoui M, El Bahloul M, Bennis A, Chra\u00efbi F, Najdi A, Benatiya IA. Safety and long-term outcomes of repeated dexamethasone intravitreal implant (Ozurdex\u00ae) for the management of macular edema: real-life study. Egypt Retina J. 2021, 8:26-33. 10.4103\/erj.erj_8_21","journal-title":"Egypt Retina J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.08-2625","article-title":"Predictive value of a topical dexamethasone provocative test before intravitreal triamcinolone acetonide injection","volume":"50","author":"Breusegem C","year":"2009","unstructured":"Breusegem C, Vandewalle E, Van Calster J, Stalmans I, Zeyen T. Predictive value of a topical dexamethasone provocative test before intravitreal triamcinolone acetonide injection. Invest Ophthalmol Vis Sci. 2009, 50:573-6. 10.1167\/iovs.08-2625","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0000000000000240","article-title":"Postoperative management of trabeculectomy and glaucoma drainage implant surgery","volume":"27","author":"Panarelli JF","year":"2016","unstructured":"Panarelli JF, Nayak NV, Sidoti PA. Postoperative management of trabeculectomy and glaucoma drainage implant surgery. Curr Opin Ophthalmol. 2016, 27:170-6. 10.1097\/ICU.0000000000000240","journal-title":"Curr Opin Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s40123-022-00504-z","article-title":"Intraocular pressure changes after intravitreal fluocinolone acetonide implant: results from four European countries","volume":"11","author":"Lebrize S","year":"2022","unstructured":"Lebrize S, Arnould L, Bourredjem A, et al.. Intraocular pressure changes after intravitreal fluocinolone acetonide implant: results from four European countries. Ophthalmol Ther. 2022, 11:1217-29. 10.1007\/s40123-022-00504-z","journal-title":"Ophthalmol Ther"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2008.10.004","article-title":"The role of steroids in outflow resistance","volume":"88","author":"Clark AF","year":"2009","unstructured":"Clark AF, Wordinger RJ. The role of steroids in outflow resistance. Exp Eye Res. 2009, 88:752-9. 10.1016\/j.exer.2008.10.004","journal-title":"Exp Eye Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.5005\/jp-journals-l0028-1226","article-title":"Steroid-induced glaucoma: an avoidable irreversible blindness","volume":"11","author":"Phulke S","year":"2017","unstructured":"Phulke S, Kaushik S, Kaur S, Pandav SS. Steroid-induced glaucoma: an avoidable irreversible blindness. J Curr Glaucoma Pract. 2017, 11:67-72. 10.5005\/jp-journals-l0028-1226","journal-title":"J Curr Glaucoma Pract"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/412261-topical-prednisolone-acetate-challenge-as-a-predictor-of-intraocular-pressure-elevation-following-ozurdex-in-diabetic-macular-edema-a-retrospective-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T06:06:13Z","timestamp":1758348373000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/412261-topical-prednisolone-acetate-challenge-as-a-predictor-of-intraocular-pressure-elevation-following-ozurdex-in-diabetic-macular-edema-a-retrospective-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,19]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.92761","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,9,19]]}}}